Viewing Study NCT05355350


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-01-27 @ 5:38 PM
Study NCT ID: NCT05355350
Status: WITHDRAWN
Last Update Posted: 2025-07-24
First Post: 2022-04-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
Sponsor: Rambam Health Care Campus
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 0295-18-RMB
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View